Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(25%)
Results Posted
67%(2 trials)

Phase Distribution

Ph not_applicable
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(3)

Detailed Status

Completed3
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

completed375%
recruiting125%

Recent Activity

1 active trials
Showing 4 of 4
completednot_applicable

Engaging and Activating Cancer Survivors in Genetic Services Study

NCT04455698
recruitingnot_applicable

Technology Assisted Collaborative Care Intervention to Improve Patient-centered Outcomes in Dialysis Patients

NCT06978127
completednot_applicable

ENGAGED 2 Study: Experiences With Mammography Screening and Breast Density 2

NCT03029286
completednot_applicable

Giving Information Systematically and Transparently in Lung and GI Cancer Phase 2

NCT04179305

Clinical Trials (4)

Showing 4 of 4 trials
NCT04455698Not Applicable

Engaging and Activating Cancer Survivors in Genetic Services Study

Completed
NCT06978127Not Applicable

Technology Assisted Collaborative Care Intervention to Improve Patient-centered Outcomes in Dialysis Patients

Recruiting
NCT03029286Not Applicable

ENGAGED 2 Study: Experiences With Mammography Screening and Breast Density 2

Completed
NCT04179305Not Applicable

Giving Information Systematically and Transparently in Lung and GI Cancer Phase 2

Completed

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4